IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences IQVIA (NYSE:IQV) on March 16, 2026 launched IQVIA.ai, a unified agentic AI platform built with NVIDIA Nemotron, NeMo Agent Toolkit, Dynamo and LangChain to accelerate clinical, commercial and real-world workflows while meeting healthcare regulatory, privacy and quality standards.IQVIA reported a collaboration with NVIDIA of more than one year, filed over 100 AI-related patents, deployed more than 150 intelligent agents, and said 19 of the top 20 pharmaceutical companies have begun using IQVIA agents; expanded capabilities expected in Q4.

#IQV IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

www.stocktitan.net/news/IQV/iqvia-unveils-i...

Based on 10-day performance, these stocks are facing headwinds.

Today's momentum laggards:

1. IQV - -28.9%
2. EXPE - -27.4%
3. CSGP - -26.1%

Which ticker made your radar? Comment below!

#StockMarket #Momentum #Trading $IQV $EXPE $CSGP

Wall Street falls on third day of losses as big tech continues to decline, traders digest more jobs data Stock indexes dip as investors parse Alphabet earnings beat and falling Treasury yields.

Wall Street falls on third day of losses as big tech continues to decline, traders digest more jobs data

#comp:ind #dji #sp500 #goog #el #lly #smci #iqv #googl #btc-usd #us10y

Origin | Interest | Match

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 IQVIA (NYSE:IQV) will announce its fourth-quarter and full-year 2025 financial results before market open on Thursday, February 5, 2026. Management will host a conference call and live webcast at 9:00 a.m. Eastern Time the same day. The earnings release, financial information and presentation slides will be posted on the IQVIA Investor Relations site (http://ir.iqvia.com). Interested parties must register in advance to join the conference call; registrants receive a confirmation email with dial-in, unique passcode and registrant ID. A replay of the webcast will be available about two hours after the live event on the investor site.

#IQV IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

www.stocktitan.net/news/IQV/iqvia-to-announ...

#IQV IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

www.stocktitan.net/news/IQV/iqvia-announces...

IQVIA Reports Third-Quarter 2025 Results IQVIA (NYSE:IQV) reported Q3 2025 revenue of $4,100 million, up 5.2% year‑over‑year (3.9% at constant currency), and GAAP net income of $331 million with GAAP diluted EPS of $1.93.Adjusted results included Adjusted EBITDA $949 million, Adjusted diluted EPS $3.00, and free cash flow $772 million (up 35% YoY). R&D Solutions reported $2.6 billion in quarterly bookings (book‑to‑bill 1.15x) and a contracted backlog of $32.4 billion. Operating cash flow was $908 million. Net debt totaled $13,143 million and net leverage was 3.52x. The company reaffirmed full‑year 2025 guidance and narrowed ranges on revenue, Adjusted EBITDA, and Adjusted EPS.

#IQV IQVIA Reports Third-Quarter 2025 Results

www.stocktitan.net/news/IQV/iqvia-reports-t...

Healthcare Analytics Giant IQVIA Announces Key Leadership Change: Current FP&A Head to Take CFO Role IQVIA's SVP of Financial Planning Michael Fedock to succeed Ron Bruehlman as CFO in February 2026. Bruehlman to continue as Senior Advisor to CEO after leading key transformations since 2011.

#IQV IQVIA Announces CFO Transition in Early 2026

www.stocktitan.net/news/IQV/iqvia-announces...

CleaDeep Launches Arspura at IFA 2025, Focusing on Kitchen Air Quality Innovation CleaDeep is set to unveil its new brand Arspura at IFA 2025, aiming to enhance kitchen air quality standards in Europe with innovative technology.

CleaDeep Launches Arspura at IFA 2025, Focusing on Kitchen Air Quality Innovation #Germany #Berlin #CleaDeep #Arspura #IQV

Industry Giants Unite: IQVIA and Veeva Form Landmark Partnership to Transform Clinical Trials & Analytics Global partnership enables seamless integration of IQVIA and Veeva's software, data, and AI capabilities. Agreement includes master data sharing, clinical trials collaboration, and resolves all disputes.

#VEEV #IQV IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

www.stocktitan.net/news/VEEV/iqvia-and-veev...

Healthcare Tech Giants Unite: IQVIA and Veeva Form Groundbreaking Partnership for Clinical Trials IQVIA and Veeva establish comprehensive partnership for clinical trials and commercial solutions, resolving legal disputes. Agreement enables seamless integration of data, AI, and software platforms.

#IQV #VEEV IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

www.stocktitan.net/news/IQV/iqvia-and-veeva...

IQVIA Delivers $4B Quarter: Strong TAS Growth, $32.1B Backlog, and Beats Profit Expectations IQVIA reports Q2 earnings with $910M Adjusted EBITDA and $2.5B new bookings. See how TAS segment achieved 8.9% growth and future outlook details.

#IQV IQVIA Reports Second-Quarter 2025 Results

www.stocktitan.net/news/IQV/iqvia-reports-s...

Breakthrough IPF Drug Enters Phase 2 Trial: Rein's Novel Treatment Could Transform Pulmonary Fibrosis Care Novel multi-pathway IPF treatment begins Phase 2 trial across 50 global sites. 120-patient study evaluating breakthrough Caveolin-1 therapy. See interim data timeline.

#RNTX #IQV Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

www.stocktitan.net/news/RNTX/rein-therapeut...

#IQV
Usually has volume in the low hundreds. 140P and 150C for July. Given the chart context this can be a sell 140, buy 150. 👀 for a directional move & follow. Recommend with shares not options.

📈 Heavy institution #Equity #optionsvolume!

AM Top Equity Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NVDA 184.8K
2. #TSLA 110.9K
3. #AMZN 62.7K
4. #SOFI 37.8K
5. #IQV 28.3K

#OptionFlow #OptionsTrading #Trading

IQVIA Outperforms Healthcare Sector: Q1 Revenue $3.8B, Analytics Business Surges 7.6% Clinical research leader posts $2.70 EPS, raises 2025 revenue guidance by $275M amid strong analytics growth. See detailed segment performance analysis.

#IQV IQVIA Reports First-Quarter 2025 Results

www.stocktitan.net/news/IQV/iqvia-reports-f...

How IQVIA's New E-Requisition Technology Could Eliminate Major Clinical Trial Bottlenecks IQVIA's new digital platform replaces manual lab processes, reducing errors and administrative burden with real-time validation already adopted by top pharma companies.

#IQV IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

www.stocktitan.net/news/IQV/iqvia-laborator...

IQVIA Earnings Showcase 41% Free Cash Flow Surge, $31.1B R&D Backlog Signals Growth IQVIA delivers Q4 revenue of $3.96B with 41% YoY free cash flow growth to $2.1B. Tech & Analytics segment surges 9.5%, while maintaining $31.1B R&D backlog. 2025 guidance reaffirmed.

#IQV IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

www.stocktitan.net/news/IQV/iqvia-reports-f...

IQVIA Holdings Announces Q4 & Full Year 2024 Earnings Call Date for February 6 IQVIA Holdings will report Q4 and FY2024 financial results on February 6, 2025, pre-market, followed by a conference call at 9:00 AM ET. Pre-registration required.

#IQV IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

www.stocktitan.net/news/IQV/iqvia-to-announ...

JUST IN: ( NYSE: #IQV ) IQVIA Reports Second-Quarter 2024 Results

#StockMarket #News